NGS Sample Preparation Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Analysis Period

1.4 Market Data Reporting Unit

1.4.1 Value

1.5 Market Size Breakdown by Segment

1.5.1 Market Segmentation by Product Type

1.5.2 Market Segmentation by Application

1.5.3 Market Segmentation by End User

1.5.4 Market Segmentation by Usage Area

1.5.5 Market Segmentation by Region

1.6 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.1.1 Paid

2.1.2 Unpaid

2.1.3 P&S Intelligence Database

2.2 Primary Research

2.2.1 Breakdown of Primary Research, by Region

2.2.2 Breakdown of Primary Research, by Industry Participant

2.2.3 Breakdown of Primary Research, by Designation

2.2.4 Breakdown of Primary Research, by Company Type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Currency Conversion Rates

2.6 Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

5.1 Expanding Scope of DNA Sequencing

5.2 NGS in Clinical Oncology to Advance Personalized Treatment of Cancer

5.3 Burden of Cancer

Chapter 6. Definition of Market Segments

6.1 By Product Type

6.1.1 Consumables

6.1.1.1 Library preparation kits

6.1.1.2 Sample purification kits

6.1.1.3 Sample extraction and isolation kits

6.1.1.4 Target enrichment

6.1.1.5 Cleanup and selection kits

6.1.1.6 Microbiome DNA enrichment

6.1.1.7 Others

6.1.2 Standalone Automated Instruments

6.1.2.1 Fragment analyzers

6.1.2.2 Nucleic acid extraction/isolation systems

6.1.2.3 DNA selection instruments

6.1.2.4 DNA/RNA shearing instruments

6.1.2.5 Template preparation instruments

6.1.2.6 Ultrasonicators/sonicators

6.2 By Application

6.2.1 DNA Sequencing

6.2.2 Whole Genome Sequencing

6.2.3 RNA Sequencing

6.2.4 Methylation Sequencing

6.2.5 Others

6.3 By End User

6.3.1 Hospitals and Clinics

6.3.2 Academic and Research Institutes

6.3.3 Pharmaceutical and Biotechnology Companies

6.3.4 Other End Users

6.4 By Usage Area

6.4.1 Oncology

6.4.2 NIPT

6.4.3 Drug Discovery

6.4.4 Microbiology

6.4.5 Infectious Diseases

6.4.6 Germline Disease Risk Evaluation

6.4.7 Applied Markets

Chapter 7. Industry Outlook

7.1 Global NGS Sample Preparation Market Dynamics

7.1.1 Trends

7.1.1.1 Partnerships are key to strengthening global health systems

7.1.1.2 Customized automated NGS sample preparation platforms are preferred

7.1.2 Drivers

7.1.2.1 Emerging technologies empowering NGS of DNA

7.1.2.2 Massive growth in the life sciences and healthcare industries

7.1.3 Impact Analysis of Drivers on Market Forecast

7.1.4 Restraints

7.1.4.1 Stringent regulatory standards

7.1.4.2 High costs of NGS sample preparation instruments

7.1.5 Impact Analysis of Restraints on Market Forecast

7.2 Global Targeted DNA Sequencing Market Dynamics

7.2.1 Drivers

7.2.1.1 Increasing research on NGS and its applications

7.2.1.2 Launch of advanced targeted DNA/RNA sequencing products

7.3 U.S. Targeted DNA Sequencing Market Dynamics

7.3.1 Drivers

7.3.1.1 Rising demand for personalized medicine pharmacotherapy

7.3.1.2 Grants from government bodies for targeted sequencing studies

7.4 Global Targeted Methylation Sequencing Market Dynamics

7.4.1 Drivers

7.4.1.1 Increasing usage of biomarkers for early cancer detection and prognosis

7.4.1.2 Increasing Rising usage of targeted DNA methylation sequencing in epigenetic drug discovery

7.5 U.S. Targeted Methylation Sequencing Market Dynamics

7.5.1 Drivers

7.5.1.1 Proliferating research in diagnostics

7.6 Impact of Covid-19

7.7 Porter’s Five Forces Analysis

7.7.1 Bargaining Power of Buyers

7.7.2 Bargaining Power of Suppliers

7.7.3 Intensity of Rivalry

7.7.4 Threat of New Entrants

7.7.5 Threat of Substitutes

Chapter 8. Global Market Size and Forecast

8.1 Overview

8.2 Market Revenue, by Product Type (2019–2030)

8.2.1 Consumables Market, by Type

8.2.2 Standalone Automated Instruments Market, by Type

8.3 Market Revenue, by Application (2019–2030)

8.4 Market Revenue, by End User (2019–2030)

8.5 Market Revenue, by Usage Area (2019–2030)

8.6 Market Revenue, by Region (2019–2030)

Chapter 9. North America Market Size and Forecast

9.1 Overview

9.2 Market Revenue, by Product Type (2019–2030)

9.2.1 Consumables Market, by Type

9.2.2 Standalone Automated Instruments Market, by Type

9.3 Market Revenue, by Application (2019–2030)

9.4 Market Revenue, by End User (2019–2030)

9.5 Market Revenue, by Usage Area (2019–2030)

9.6 Market Revenue, by Country (2019–2030)

Chapter 10. Europe Market Size and Forecast

10.1 Overview

10.2 Market Revenue, by Product Type (2019–2030)

10.2.1 Consumables Market, by Type

10.2.2 Standalone Automated Instruments Market, by Type

10.3 Market Revenue, by Application (2019–2030)

10.4 Market Revenue, by End User (2019–2030)

10.5 Market Revenue, by Usage Area (2019–2030)

10.6 Market Revenue, by Country (2019–2030)

Chapter 11. APAC Market Size and Forecast

11.1 Overview

11.2 Market Revenue, by Product Type (2019–2030)

11.2.1 Consumables Market, by Type

11.2.2 Standalone Automated Instruments Market, by Type

11.3 Market Revenue, by Application (2019–2030)

11.4 Market Revenue, by End User (2019–2030)

11.5 Market Revenue, by Usage Area (2019–2030)

11.6 Market Revenue, by Country (2019–2030)

Chapter 12. LATAM Market Size and Forecast

12.1 Overview

12.2 Market Revenue, by Product Type (2019–2030)

12.2.1 Consumables Market, by Type

12.2.2 Standalone Automated Instruments Market, by Type

12.3 Market Revenue, by Application (2019–2030)

12.4 Market Revenue, by End User (2019–2030)

12.5 Market Revenue, by Usage Area (2019–2030)

12.6 Market Revenue, by Country (2019–2030)

Chapter 13. MEA Market Size and Forecast

13.1 Overview

13.2 Market Revenue, by Product Type (2019–2030)

13.2.1 Consumables Market, by Type

13.2.2 Standalone Automated Instruments Market, by Type

13.3 Market Revenue, by Application (2019–2030)

13.4 Market Revenue, by End User (2019–2030)

13.5 Market Revenue, by Usage Area (2019–2030)

13.6 Market Revenue, by Country (2019–2030)

Chapter 14. Competitive Landscape

14.1 Key Players

14.1.1 Illumina Inc.

14.1.2 Agilent Technologies Inc.

14.1.3 Thermo Fisher Scientific Inc.

14.1.4 ArcherDX Inc.

14.1.5 Twist Bioscience Corporation

14.1.6 Integrated DNA Technologies Inc.

14.1.7 Swift Biosciences Inc.

14.1.8 F. Hoffmann-La Roche Ltd.

14.2 Recent Strategic Developments of Key Players

14.2.1 Partnerships & Collaborations

14.2.2 Product Launches

14.2.3 Mergers & Acquisitions

14.2.4 Other Developments

Chapter 15. Company Profiles

15.1 Illumina Inc.

15.1.1 Business Overview

15.1.2 Product and Service Offerings

15.1.3 Key Financial Summary

15.2 Thermo Fisher Scientific Inc.

15.2.1 Business Overview

15.2.2 Product and Service Offerings

15.2.3 Key Financial Summary

15.3 F. Hoffmann-La Roche Ltd.

15.3.1 Business Overview

15.3.2 Product and Service Offerings

15.3.3 Key Financial Summary

15.4 ArcherDX Inc.

15.4.1 Business Overview

15.4.2 Product and Service Offerings

15.5 Pacific Biosciences of California Inc.

15.5.1 Business Overview

15.5.2 Product and Service Offerings

15.5.3 Key Financial Summary

15.6 Integrated DNA Technologies Inc.

15.6.1 Business Overview

15.6.2 Product and Service Offerings

15.7 Becton, Dickinson and Company

15.7.1 Business Overview

15.7.2 Product and Service Offerings

15.7.3 Key Financial Summary

15.8 Twist Bioscience Corporation

15.8.1 Business Overview

15.8.2 Product and Service Offerings

15.8.3 Key Financial Summary

15.9 QIAGEN N.V.

15.9.1 Business Overview

15.9.2 Product and Service Offerings

15.9.3 Key Financial Summary

15.10 Beckman Coulter Inc.

15.10.1 Business Overview

15.10.2 Product and Service Offerings

15.11 Agilent Technologies Inc.

15.11.1 Business Overview

15.11.2 Product and Service Offerings

15.11.3 Key Financial Summary

15.12 New England Biolabs Inc.

15.12.1 Business Overview

15.12.2 Product and Service Offerings

15.13 Danaher Corporation

15.13.1 Business Overview

15.13.2 Product and Service Offerings

15.14 Oxford Nanopore Technologies plc

15.14.1 Business Overview

15.14.2 Product and Service Offerings

15.15 Bio-Rad Laboratories Inc.

15.15.1 Business Overview

15.15.2 Product and Service Offerings

Chapter 16. Appendix

16.1 Sources and References

16.2 Related Reports